In some publications, the authors suggested that the resistance of the tumour cells to anti-cancer drugs, such as epirubicin or DOX, is overcome by the impact of MLT on the inhibition of P-glycoprotein expression via the nuclear factor kappa B (NF-kB) pathway [22,44,45]. Here, NFKB1 is linked to cancer.